Lowest Price Guaranteed
Slides
236
Last Updated
June 2025
View Count
5740
The global cold plasma market, valued at USD 2.43 billion in 2024, is projected to reach USD 2.82 billion in 2025 and USD 9.39 billion by 2035, representing a CAGR of 12.8% during the forecast period.
 |
To learn more about this report, request a free sample copy
Cold plasma is a partially ionized gas which is created by passing electric current through a gas. It is also known as non-equilibrium plasma as the constituent temperature vary significantly. Cold plasma technology is widely adopted in aerospace industries and automotive industries, primarily to enhance surface treatment, adhesion, coating quality and wettability along with etching processes. Key companies focusing on development of products for surface treatment / engineering using cold plasma include Adtec Plasma Technology (Japan), Europlasma NV (Belgium), Henniker Plasma (UK), Nordson Corporation (US), Plasmatreat (Germany), Tantec A/S (Denmark) and Thierry Corporation (US).
Cold plasma technology in food processing is increasingly used for microbial decontamination, offering a non-thermal alternative to increase the shelf-life. As of now, the development of cold plasma therapy for medical applications is very active. It is generally used to sterilize medical equipment, for advance wound care and skin rejuvenation. Several research also suggests that cold plasma is highly effective in removing airborne viruses, making it an ideal treatment modality for patients suffering from breathing problems. Key companies in this segment include Adtec Healthcare Limited (UK), Apyx Medical (US), Neoplas Med (Germany) and US Medical Innovations (US). Companies like hyped science GmbH are developing cold plasma device for skin rejuvenation.
Considering the emerging opportunities in this field, various industrial players are undertaking strategic initiatives followed by the latest launch, collaborations, investments and partnerships. These consistent innovations, broad acceptance in different industrial verticals and strategic initiatives by industrial players make cold plasma market highly competitive and investible for the long term.
The market report provides comprehensive information on industrial players who are currently active across various segments of the cold plasma industry as mentioned in the table below.
| Key Report Attributes | Details | |
| Historical Trend | Since 2020 | |
| Forecast Period | Till 2035 | |
| Current Market Size | USD 2.82 Billion | |
| Market Size 2035 | USD 9.39 Billion | |
| CAGR (Till 2035) | 12.8% | |
| Type of Pressure |
|
|
| Type of Technology |
|
|
| Application Areas |
|
|
| End Users |
|
|
| Geographical Regions |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
Available | |
One of the key objectives of the cold plasma market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.
The global market analysis report also features the likely distribution of the current and forecasted opportunity within the market across various segments, such type of pressure (low-pressure cold plasma and atmospheric pressure cold plasma), type of technology (corona discharge, dielectric barrier discharge (DBD), gliding arc discharge, resistive barrier discharge system, plasma needle, and AP plasma jet), application areas (adhesion, sterilization and disinfection, etching, decontamination, surface treatment, coating, finishing, printing, wound healing and other applications), end users (hospitals, textile, electronics and semiconductor, polymers and plastic, agriculture, food processing and packaging, aerospace, automotive, and other end users), geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and leading players.
In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three cold plasma market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. The financial figures mentioned in this market report are in USD, unless otherwise specified.
The global market is segmented into low-pressure cold plasma and atmospheric pressure cold plasma. Currently, the atmospheric pressure cold plasma segment accounts for 71% of the overall cold plasma market share. This is primarily due to the increasing usage of atmospheric pressure cold plasma technology within the healthcare industry for chronic wound treatment. Moreover, atmospheric pressure cold plasma is environmentally friendly and safe to use for wide range of medical applications.
However, the low-pressure cold plasma segment is expected to grow at a higher CAGR during the forecast period. This lucrative growth is driven by the growing adoption of low-pressure cold plasma technology to remove airborne pathogens and sterilization of medical device.
This segment highlights the distribution of global market across different types of technology, such as corona discharge, dielectric barrier discharge (DBD), gliding arc discharge, resistive barrier discharge system, plasma needle, and AP plasma jet.
According to our cold plasma market forecast, currently AP plasma jet and dielectric barriers segments are dominating the market. This can be attributed to the fact that plasma jets and dielectric barriers are higher versatile and offer better control during plasma delivery. Driven by efficiency, these segments will continue to gain momentum and are likely to grow at a higher CAGR during the forecast period.
The global market is distributed across different application areas, such as adhesion, sterilization and disinfection, etching, decontamination, surface treatment, coating, finishing, printing, wound healing and other applications.
Among these, wound healing segment currently holds the highest cold plasma market share (33%). This is primarily due to the widespread usage of cold plasma technology for treating wounds and faster tissue regeneration. Moreover, medical professionals are also using this technology to reduce risk of infection at the site of infection, which has further contributed to the highest share of the segment.
However, in the long run, the finishing segment is anticipated to grow at a higher CAGR during the forecast period. This is potentially due to the fact that cold plasma technology plays a significant role in textile industry for surface hydrophobization of the fiber. Moreover, wetting properties, anti-microbial activity and self-cleaning properties is further expanding their usage across textile industry for finishing purpose.
Based on the end user, the global market is segmented into hospitals, textile, electronics and semiconductors, polymers and plastic, agriculture, food processing and packaging, aerospace, automotive, and other end users.
According to our cold plasma market report, currently the hospital sub segment accounts for the highest share (nearly 45%) of the market. This is primarily due to the fact that hospitals are the primary user of cold plasma technologies to control nosocomial infection / hospital acquired infection, wound treatment and removal of airborne pathogens in hospitals.
Moreover, cold plasma technology is widely used for sterilization of medical equipment in hospitals, which has further contributed to the highest share of hospitals. It is worth mentioning here that driven by the increasing adoption in hospitals, this segment is likely to grow at a higher CAGR during the forecast period.
The global market is distributed across different geographical regions, such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. It is worth mentioning that currently, North America accounts for the highest share (41%) of the market.
However, in Asia-Pacific, the market for cold plasma is likely to grow at a higher CAGR during the forecast period. This is primarily due to the growing geriatric population with chronic wounds and diseases. Moreover, the rising demand for cold plasma technologies in hospitals for sterilization, and surface treatment in automotive and the textile industry is likely to fuel its demand in this region.
The “Cold Plasma Market: Industry Trends and Global Forecasts, till 2035” report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics, and future opportunities for cold plasma industrial players. The market research report lays emphasis on the cold plasma products that are being developed. Key takeaways of the market report are briefly discussed below.
The market landscape of cold plasma is highly competitive, featuring a wide array of well-established and new entrants. Currently, the primary focus on industrial players is on technological innovations and exploring new applications of cold plasma technologies. Plasmatreat (Germany) provides Openair-Plasma® Jets to clients for surface treatment. In January 2025, Plasmatreat launched PFW10LT Openair-Plasma nozzle (a low temperature nozzle) specifically designed to activate thermally sensitive surfaces and materials such as plastics.
In order to leverage a competitive edge, several market players are entering into partnerships and collaborations.
As more market players continue to explore more innovative cold plasma technologies, this market will remain competitive throughout the projection period, offering opportunities to industrial players for strategic initiatives.
Cold plasma technology has significantly gained traction in the healthcare industry as a potential sterilization method for medical equipment and wound treatment. Notably, with growing incidence of chronic diseases, such as diabetes that may result into chronic wounds has necessitated the demand for advanced wound healing technologies. Cold plasma market growth in medical devices and wound healing is being driven by its higher effectiveness in reducing infection at wound sites and promoting tissue regeneration for quick healing.
In addition, the healthcare industry is also adopting cold plasma technology to reduce pathogenic infection in hospitals, which has further fueled its demand in the medical industry. Furthermore, industrial players are exploring more applications of cold plasma technologies, such as cancer treatment at various stages. However, the primary focus on industrial players will be on development of advanced chronic condition treatment and infection prevention.
Some of the major challenges in cold plasma market that are impeding growth include lack of standardization and technological complexities. It is important to highlight here that regulatory authorities still does not provide standardized protocols for cold plasma technologies which makes it difficult for industrial players to get approval and commercialize it on a large scale.
Moreover, cold plasma generation is a complex procedure as it involves chemical and physical processes that further lead to variability in plasma properties. The complexity associated with cold plasma generation may create challenges to achieve consistent results. Additionally, scaling cold plasma technology from laboratory to industrial level can be time consuming, expensive and challenging, creating a barrier for market leaders.
Despite the challenges, the market for cold plasma is consistently growing driven by the ongoing expansion of cold plasma technologies beyond the healthcare industry. Plasma Fresh, a University of Liverpool spin-out, is developing cold plasma technology to eliminate contamination from food and the food processing environment.
The industrial players are also emphasizing the development of sustainable atmospheric pressure cold plasma that eliminates the requirement of vacuum chambers, and surface modification in the aerospace industry, while minimizing the impact on material properties.
Furthermore, the skincare industry will provide a huge opportunity area for cold plasma technology companies. In June 2025, hyped science GmbH launched PHLAS, a groundbreaking cold plasma device for medical aesthetic applications. The handheld device based on patented SMD cold plasma technology, allows skin rejuvenation in homecare settings.
A number of companies evaluating cold plasma technology for medical applications have raised funds in the recent past. In November 2024, Niterra Ventures invested USD 18 million in Neoplas Med (Greifswald-based company) to expand the development of wound care technology. Neoplas Med has created an argon cold plasma jet, kINPen® MED (smart plasma pen) that directs precise plasma jet onto wounds for faster healing. Another company Viromed Medical announced raising funds through private placement in February 2025. They are developing PulmoPlas, a medical device that utilizes cold atmospheric pressure plasma (CAP) technology for treating ventilator-associated pneumonia (VAP). The funding will support the commercialization of the device in European markets.
In February 2025, Royal Wound X announced a strategic partnership with Coldplasmatech (innovator in medical cold plasma technology) to transform the chronic wound treatment landscape worldwide. Under this agreement, Coldplasmatech’s innovative Cold Atmospheric Plasma technology that consist of CPT®patch (specialized wound applicator) and CPT®cube (automated control device), offer an effective and safe therapy to heal complex wounds.
Currently, the global cold plasma industry is valued at USD 2.82 billion and is poised to reach USD 9.39 billion, expecting to grow at a CAGR of 12.8% during the forecast period. Notably, the market players such as Neoplas Med, Adtech Healthcare and CINOGY System are taking strategic initiatives, such as partnerships, acquisitions and mergers to strengthen their product portfolio and expand their research on cold plasma technology.
Examples of key players engaged in this domain (which have also been captured in this report) include Adtec Plasma Technology, Apyx Medical, Coating Plasma Innovation, Cinogy Technologies, Enercon Industries, Henniker Plasma, Europlasma, Molecular Plasma Group, Nordson, Neoplas Med, Plasmatreat, Relyon Plasma, Surfx Technologies, Softal Corona & Plasma, Tantec, Thierry, Terraplasma and US Medical Innovations. This market report includes an easily searchable excel database of all the companies focusing on the development of cold plasma products.
The market report presents an in-depth analysis, highlighting the capabilities of various companies engaged in this domain across different segments. Amongst other elements, the market report includes:
Several recent developments have taken place in the field of cold plasma. We have outlined some of these recent initiatives below.